Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Harrow, Inc.(HROW) | 3,955,000 | 3,905,000 | -50,000 | $105.20M | $119.26M | 24.13% | +$14.06M |
| Eton Pharmaceuticals, Inc.(ETON) | 2,852,070 | 2,860,000 | +7,930 | $37.02M | $40.76M | 8.25% | +$3.74M |
| Immunome, Inc.(IMNM) | 3,550,000 | 3,529,581 | -20,419 | $23.89M | $32.83M | 6.64% | +$8.93M |
| SANUWAVE Health, Inc.(SNWV) | 972,002 | 980,000 | +7,998 | $34.38M | $32.20M | 6.52% | -$2.18M |
| Liquidia Corporation(LQDA) | 2,260,000 | 2,475,000 | +215,000 | $33.34M | $30.84M | 6.24% | -$2.50M |
| Codexis, Inc.(CDXS) | 9,500,000 | 12,600,000 | +3,100,000 | $25.55M | $30.74M | 6.22% | +$5.19M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 490,000 | 475,000 | -15,000 | $25.96M | $30.02M | 6.07% | +$4.06M |
| TG Therapeutics, Inc.(TGTX) | 535,000 | 535,000 | 0 | $21.10M | $19.25M | 3.90% | -$1.84M |
| Ocular Therapeutix, Inc.(OCUL) | 1,595,000 | 1,595,000 | 0 | $11.69M | $14.80M | 3.00% | +$3.11M |
| Arvinas, Inc.(ARVN) | 1,975,000 | 1,680,000 | -295,000 | $13.86M | $12.36M | 2.50% | -$1.50M |
| Larimar Therapeutics, Inc.(LRMR) | 1,914,077 | 4,110,000 | +2,195,923 | $4.12M | $11.88M | 2.40% | +$7.76M |
| Disc Medicine, Inc.(IRON) | 85,000 | 186,418 | +101,418 | $4.22M | $9.87M | 2.00% | +$5.65M |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 500,000 | +500,000 | $0 | $8.55M | 1.73% | +$8.55M |
| Vigil Neurosciences Inc | 0 | 1,000,000 | +1,000,000 | $0 | $7.95M | 1.61% | +$7.95M |
| CG Oncology, Inc.(CGON) | 163,988 | 266,000 | +102,012 | $4.02M | $6.92M | 1.40% | +$2.90M |
| Xoma Corp Del | 253,043 | 255,087 | +2,044 | $5.04M | $6.43M | 1.30% | +$1.39M |
| Edgewise Therapeutics, Inc.(EWTX) | 395,000 | 490,000 | +95,000 | $8.69M | $6.42M | 1.30% | -$2.27M |
| Stoke Therapeutics, Inc.(STOK) | 300,000 | 562,120 | +262,120 | $2.00M | $6.38M | 1.29% | +$4.39M |
| Anika Therapeutics Inc | 395,000 | 588,797 | +193,797 | $5.94M | $6.23M | 1.26% | +$292.6K |
| Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS) | 0 | 0 | 0 | $6.32M | $5.95M | 1.20% | -$370.4K |
| Protagonist Therapeutics Inc | 105,000 | 105,000 | 0 | $5.08M | $5.80M | 1.17% | +$725.5K |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 1,195,000 | 500,000 | -695,000 | $6.81M | $5.63M | 1.14% | -$1.19M |
| Karyopharm Therapeutics IncNOTE 3 000 10 1 | 0 | 0 | 0 | $4.56M | $4.56M | 0.92% | -$840 |
| Gossamer Bio, Inc.(GOSS) | 4,287,415 | 3,545,000 | -742,415 | $4.72M | $4.36M | 0.88% | -$355.8K |
| Rezolute, Inc.(RZLT) | 465,000 | 903,442 | +438,442 | $1.35M | $4.03M | 0.82% | +$2.68M |
| Revolution Medicines, Inc.(RVMD) | 0 | 105,000 | +105,000 | $0 | $3.86M | 0.78% | +$3.86M |
| Essa Pharma Inc | 2,209,998 | 2,209,998 | 0 | $3.49M | $3.76M | 0.76% | +$265.2K |
| Cargo Therapeutics Inc | 666,503 | 666,503 | 0 | $2.71M | $2.75M | 0.56% | +$33.3K |
| MBX Biosciences, Inc.(MBX) | 250,000 | 239,319 | -10,681 | $1.84M | $2.73M | 0.55% | +$885.6K |
| Zymeworks Inc.(ZYME) | 175,000 | 210,000 | +35,000 | $2.08M | $2.64M | 0.53% | +$551.3K |
| Protara Therapeutics, Inc.(TARA) | 1,730,000 | 855,000 | -875,000 | $7.37M | $2.59M | 0.52% | -$4.78M |
| Alumis Inc | 0 | 775,000 | +775,000 | $0 | $2.33M | 0.47% | +$2.33M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 1,985,000 | 1,924,300 | -60,700 | $3.16M | $2.23M | 0.45% | -$924.0K |
| Trevi Therapeutics, Inc.(TRVI) | 795,000 | 390,000 | -405,000 | $5.00M | $2.13M | 0.43% | -$2.87M |
| AVITA Medical, Inc.(RCEL) | 440,000 | 389,519 | -50,481 | $3.58M | $2.06M | 0.42% | -$1.52M |
| Opus Genetics, Inc.(IRD) | 1,175,000 | 1,220,000 | +45,000 | $1.55M | $1.15M | 0.23% | -$397.0K |
| Journey Medical Corporation(DERM) | 69,323 | 95,000 | +25,677 | $409.0K | $682.1K | 0.14% | +$273.1K |
| Elevation Oncology Inc | 0 | 1,442,061 | +1,442,061 | $0 | $529.4K | 0.11% | +$529.4K |
| iBio, Inc.(IBIO) | 375,000 | 375,000 | 0 | $1.51M | $285.0K | 0.06% | -$1.22M |
| PepGen Inc.(PEPG) | 420,000 | 240,000 | -180,000 | $590.1K | $266.4K | 0.05% | -$323.7K |
| Adagio Medical Holdings, Inc.(ADGM) | 110,571 | 110,571 | 0 | $92.1K | $143.7K | 0.03% | +$51.6K |
| Acelyrin Inc | 1,615,000 | 0 | -1,615,000 | $3.99M | $0 | — | -$3.99M |
| Anaptys Bio Inc | 250,933 | 0 | -250,933 | $4.66M | $0 | — | -$4.66M |
| Biodesix, Inc.(BDSX) | 3,225,000 | 0 | -3,225,000 | $2.02M | $0 | — | -$2.02M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 62,501 | 0 | -62,501 | $1.39M | $0 | — | -$1.39M |
| Nurix Therapeutics, Inc.(NRIX) | 115,000 | 0 | -115,000 | $1.37M | $0 | — | -$1.37M |
| Optinose Inc | 193,039 | 0 | -193,039 | $1.77M | $0 | — | -$1.77M |
| Palvella Therapeutics, Inc.(PVLA) | 172,357 | 0 | -172,357 | $4.82M | $0 | — | -$4.82M |
| Sangamo Therapeutics, Inc.(SGMOQ) | 1,055,000 | 0 | -1,055,000 | $691.9K | $0 | — | -$691.9K |
| Ventyx Biosciences Inc | 190,000 | 0 | -190,000 | $218.5K | $0 | — | -$218.5K |